Glenmark and BeiGene Enter into an Agreement for Marketing and Distribution of Tislelizumab and Zanubrutinib in India
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Stay updated with breaking news from Udaykumar Murthy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Press Release For Immediate Distribution ...
Cosmo Pharmaceuticals N.V. / Key word(s): Contract27-Sep-2023 / 06:00 GMT/BSTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement. Cassiopea, the subsidiary of Cosmo, will be responsible for Centralized Marketing Authorization at European Medic...
Ad hoc announcement pursuant to Art. 53 LR Cassiopea, the subsidiary of Cosmo, will be responsible for Centralized Marketing Authorization at European...
/CNW Telbec/ - Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC) ("Bausch Health") and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd....